DEPLANTIS LTD
Company number 12223098 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£706,819
Balance sheet as at 2025-09-30
What it does
The principal activity of the company is medicines
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-09-23
- Employees
- 3 (2025 accounts)
- Registered office
- Limbco Ltd, Plough Lane, Hereford, United Kingdom, HR4 0EL
- Postcode
- HR4 0EL
- Capital
- 148 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-09-30
- Next due by
- 2027-06-30
- Financial year end
- 30 September
Confirmation statement
- Last statement dated
- 2025-09-22
- Next due by
- 2026-10-06
Nature of business (SIC)
- 21100 Manufacture of basic pharmaceutical products
Officers 3 current
Contact details
- Website
- deplantis.uk
- Phone
- 01432373536
Centoreze - A herbal medicine used for the relief of common cold symptoms. Pelargonium extract, the active ingredient in Centoreze, has broad antiviral properties.
Among its peers
Top 25%
by shareholders' funds, of 865 similar companies in HR — measured against the wider sector
Trading since 2019.
The class of 2019
33%
of the 690,899 companies incorporated in 2019 are still active today; 58% have since been dissolved.
A fact about the year, not a forecast for this company.